ASE Technology August Net Revenues Rise 34.6% YoY To $2.556B, Up 10.7% Sequentially From July
Aug Jul Aug Sequential YoY(US$ Million) 2026 2026 2025 Change ChangeNet Revenues 2,556 2,309 1,899 +10.7 % +34.6 %
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Aug Jul Aug Sequential YoY(US$ Million) 2026 2026 2025 Change ChangeNet Revenues 2,556 2,309 1,899 +10.7 % +34.6 %
https://www.bloomberg.com/news/articles/2026-09-09/unitedhealth-sells-interest-in-florida-wellmed-clinics-to-tpg
BTIG analyst Gregory Lewis maintains Canaan (NASDAQ:CAN) with a Buy and lowers the price target from $3 to $2.
InnovAge shares climbed 10.25% after hours after fourth-quarter revenue beat estimates and the company issued fiscal 2027 guidance.
Pyxis Oncology shares gained 9.25% after hours following a leadership update and ahead of Wednesday’s clinical data webcast.
Cryptocurrency analyst Willy Woo on Tuesday, September 8, projected a Bitcoin price range of $220,000 to $600,000 within the next 3 to 5 years.
Foldable iPhone could prioritize an ultra-thin, premium design over Pro-level features, potentially trading Face ID and telephoto zoom.
Jim Chanos questions Nvidia's GPU rental economics, challenging Jensen Huang: if the chips are so durable, why not rent them out yourself?
Carney says Canada is ending overreliance on the U.S., retaliating against tariffs and diversifying trade with trusted partners.
Some state lawmakers, including Ohio State Rep. Tristan Rader, D-Lakewood, want to repeal the sales-tax exemption and renegotiate previous deals with big tech companies for data centers.
ServiceTitan shares fall 20% after hours following quarterly results and fiscal 2027 guidance.
Core & Main reports Q2 earnings Sept. 9; analysts expect EPS to rise to 86¢ and revenue to reach $2.14B from $2.09B.
On Wednesday, Braze (NASDAQ:BRZE) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data
First-in-human Phase 1 study initiated for investigational antibodies targeting orthopoxviruses developed under U.S. Department of War Accelerated Antibodies ProgramSupports development of countermeasures
Market sentiment weakened as Fear & Greed fell to 40.5. U.S. stocks declined amid Middle East tensions; investors await inflation data.
Green Circle Decarbonize Technology shares fall 22% after hours following SANVO partnership for China panel production.
Apple shares have a strange habit around iPhone launches: slip on reveal day, then bounce back higher the next session.